top of page
The Professional Network for Healthcare Experts
Third Rock Ventures signs AI antibody discovery partnership with Funnel Biosciences worth up to $2.16 billion
Third Rock Ventures has entered a potentially $2.16 billion AI-enabled antibody discovery collaboration with China's Funnel Biosciences, combining epitope-guided molecular design with multiple venture-selected drug targets.
nuaxia
27 minutes ago2 min read
Biocytogen licenses fully human VHH antibody to Qilu Pharmaceutical for neuroscience development
Biocytogen has granted Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody from its RenNano platform for the development of neuroscience therapies.
nuaxia
Sep 32 min read
bottom of page